Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis

Stock Information for NCS Multistage Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NCS Multistage Holdings Inc.

Are PRTH, MG, AEMD Obtaining Fair Deals for their Shareholders?
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD)
Halper Sadeh LLC is Investigating Whether AEMD, CSR, ATKR are Obtaining Fair Deals for their Shareholders
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruger & Company, Inc. (NYSE - RGR), Atkore, Inc. (NYSE - ATKR), Centerspace (NYSE - CSR), Aethlon Medical, Inc. (Nasdaq - AEMD)
AEMD Stock Alert: Halper Sadeh LLC is Investigating Whether Aethlon Medical, Inc. is Obtaining a Fair Price for its Shareholders
Presenting on Emerging Growth Conference 95 Day 1 on August 19; Register to live stream
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.